Michael L. Blum - 09 Jan 2023 Form 4/A - Amendment Insider Report for Homology Medicines, Inc. (QTTB)

Role
Chief Commercial Officer
Signature
/s/ Paul Alloway, Attorney-in-Fact for Michael L. Blum
Issuer symbol
QTTB
Transactions as of
09 Jan 2023
Net transactions value
$0
Form type
4/A - Amendment
Filing time
20 Jan 2023, 15:05:27 UTC
Date Of Original Report
11 Jan 2023
Previous filing
04 Jan 2023
Next filing
27 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding FIXX Common Stock 9,408 09 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This amended Form 4 is being filed to correct the aggregate common stock holdings of the Reporting Person. On each of January 4, 2023 and January 11, 2023, the Reporting Person filed a Form 4 that inadvertently re-reported Employee Stock Purchase Plan ("ESPP") shares that were previously reported. Accordingly, the common stock holdings in column 5 of Table I have been reduced by 630 ESPP shares.